Blood Pressure Monitoring
Overview
Non-invasive tail-cuff blood pressure measurement provides repeated, longitudinal hemodynamic monitoring in conscious mice without surgical instrumentation. The animal is placed in a clear acrylic restraint tube mounted on a warming platform maintained at 32-34 degrees C to ensure adequate tail blood flow and vasodilation. A pneumatic occlusion cuff encircles the proximal tail, and a distal volume-pressure recording (VPR) sensor or photoelectric plethysmograph detects the pulsatile blood flow signal. ConductMaze controls the entire measurement cycle: the cuff inflates to a supra-systolic pressure (typically 200 mmHg), then deflates at a controlled linear rate (3-6 mmHg/second) while the plethysmographic sensor detects the return of pulsatile flow. The point of pulse reappearance corresponds to systolic blood pressure, while diastolic pressure is computed from the point of maximum pulse amplitude or from the disappearance of the characteristic waveform distortion during continued deflation.
ConductMaze performs 15-25 inflation-deflation cycles per session, with the first 5-10 cycles designated as acclimation (data discarded) to allow the animal to habituate to the restraint and cuff inflation. The remaining cycles are used for measurement, and the software applies automatic outlier rejection based on signal quality metrics — rejecting cycles with excessive motion artifact, insufficient pulse amplitude, or aberrant waveform morphology. This approach yields highly reproducible systolic, diastolic, and mean arterial pressure (MAP) values that correlate well with telemetry gold-standard measurements when proper technique is observed. The method is widely used in hypertension research (Ang II infusion, DOCA-salt, L-NAME, SHR), renal disease models, metabolic syndrome (high-fat diet), and cardiovascular drug screening.
ConductMaze logs each inflation-deflation cycle with raw cuff pressure trace, plethysmographic waveform, computed systolic/diastolic/MAP values, heart rate derived from inter-pulse intervals, and signal quality score. The software computes session means and standard deviations after outlier rejection, generates trend plots across multi-day measurement campaigns, and supports automated scheduling for circadian blood pressure profiling. All raw waveforms are archived, enabling retrospective re-analysis with adjusted detection algorithms. The system supports up to 8 simultaneous restraint platforms for parallel measurement, dramatically increasing throughput for large cohort studies.
Trial Flow
Platform Warming
Preheat warming platform to 33°C and verify temperature stability
Animal Restraint
Place mouse in acrylic restraint tube with tail extended through cuff and sensor
Acclimation Cycles
Run 5-10 inflation-deflation cycles (data discarded) for habituation
Measurement Cycles
Execute 15 measurement inflation-deflation cycles at controlled deflation rate
Pulse Detection
Plethysmograph detects pulse return during deflation? Mark systolic pressure point
Outlier Rejection
Signal quality score above threshold? Accept cycle for analysis or flag as rejected
BP Computation
Calculate systolic, diastolic, MAP, and heart rate from accepted cycles
Session End
Export mean BP values, cycle-by-cycle data, and signal quality report; release animal
Parameters
| Parameter | Type | Default | Description |
|---|---|---|---|
| Max Cuff Pressure | integer | 200 | Maximum inflation pressure in mmHg — must exceed expected systolic BP |
| Deflation Rate | float | 4.0 | Cuff deflation rate in mmHg/second during measurement phase |
| Warming Temperature | float | 33.0 | Platform surface temperature in °C to promote tail vasodilation |
| Acclimation Cycles | integer | 5 | Number of initial inflation cycles discarded for habituation |
| Measurement Cycles | integer | 15 | Number of inflation-deflation cycles used for BP determination |
| Outlier Rejection Threshold | float | 2.0 | Standard deviations from running mean beyond which a cycle is rejected |
| Inter-Cycle Delay | seconds | 15 | Rest interval between successive inflation-deflation cycles |
| Restraint Timeout | duration | 1200 | Maximum total restraint time in seconds to limit stress effects |
Metrics
| Metric | Unit | Description |
|---|---|---|
| Systolic Blood Pressure | mmHg | Mean systolic pressure across accepted measurement cycles |
| Diastolic Blood Pressure | mmHg | Mean diastolic pressure across accepted measurement cycles |
| Mean Arterial Pressure | mmHg | MAP computed as diastolic + 1/3(systolic - diastolic) averaged across accepted cycles |
| Heart Rate | bpm | Heart rate derived from inter-pulse intervals in the plethysmographic waveform |
| Pulse Amplitude | AU | Mean plethysmographic pulse amplitude — reflects peripheral vascular tone and blood volume |
| BP Variability | mmHg SD | Standard deviation of systolic BP across accepted cycles within a session |
| Accepted Cycle Count | count | Number of measurement cycles passing quality criteria — minimum 8 recommended |
| Rejection Rate | % | Percentage of measurement cycles rejected due to motion artifact or poor signal quality |
Sample Data
| Subject | Group | Systolic_mmHg | Diastolic_mmHg | MAP_mmHg | HR_bpm | Pulse_Amp | Accepted_Cycles |
|---|
Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.
Applications
- 1Hypertension research — longitudinal BP monitoring in Angiotensin II infusion, DOCA-salt, L-NAME, and spontaneously hypertensive rat/mouse models.
- 2Cardiovascular drug screening — evaluating antihypertensive efficacy of ARBs, ACE inhibitors, calcium channel blockers, and novel compounds through dose-response BP curves.
- 3Metabolic syndrome — tracking blood pressure elevation in high-fat diet, db/db, and ob/ob models alongside glucose tolerance and body composition.
- 4Renal disease — monitoring hypertension development in 5/6 nephrectomy, UUO, and polycystic kidney disease models as a functional cardiovascular endpoint.
- 5Pregnancy hypertension — characterizing blood pressure changes in RUPP (reduced uterine perfusion pressure) and sFlt-1 preeclampsia models across gestational timepoints.
Compatible Products
Ready to Automate Your Behavioral Protocols?
Contact us for a demo and pricing information.